Decreased susceptibility of mice to infection with Listeria monocytogenes in the absence of interleukin-18.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 2519415)

Published in Infect Immun on June 23, 2008

Authors

Matthias Lochner1, Kathrin Kastenmüller, Michael Neuenhahn, Heike Weighardt, Dirk H Busch, Wolfgang Reindl, Irmgard Förster

Author Affiliations

1: Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.

Articles cited by this

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33

Immune responses to Listeria monocytogenes. Nat Rev Immunol (2004) 5.91

Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol (2001) 5.02

Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity (1998) 4.85

Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity (1998) 4.70

Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol (2001) 4.38

Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med (2004) 4.34

Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med (2004) 3.94

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest (1998) 3.54

Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med (2004) 3.06

Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol (1999) 2.79

Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73

Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol (2002) 2.61

MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J Immunol (2002) 2.60

Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol (2002) 2.54

Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev (2001) 2.52

Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol (2000) 2.49

Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol Rev (1997) 2.47

Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol (1998) 2.23

Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun (1999) 2.14

Immunity to Listeria infection. Curr Opin Immunol (2000) 1.97

Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics (1983) 1.96

Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun (1999) 1.85

Roles of caspase-1 in Listeria infection in mice. Int Immunol (2004) 1.78

Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol (1998) 1.77

Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr Opin Immunol (1997) 1.74

Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med (2006) 1.69

Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol (2001) 1.60

Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest (2001) 1.59

Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J Immunol (2004) 1.58

Lymphocyte apoptosis during early phase of Listeria infection in mice. Am J Pathol (1997) 1.55

Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol (2001) 1.50

A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J Exp Med (2001) 1.48

Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med (Berl) (2001) 1.44

IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol (1998) 1.33

Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol (2002) 1.28

IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J Immunol (2003) 1.26

A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem (2001) 1.23

Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol (1999) 1.22

Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol (2004) 1.21

IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J Immunol (2000) 1.17

In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine (1999) 1.16

A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol (2001) 1.14

Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections. Infect Immun (1999) 1.09

Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect Immun (2000) 1.09

Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res (1997) 1.05

Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes. Infect Immun (1998) 1.03

NK dendritic cells are innate immune responders to Listeria monocytogenes infection. J Immunol (2007) 1.01

Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut (2004) 1.01

Airway epithelium expresses interleukin-18. Eur Respir J (1999) 0.98

Chemoattraction of human T cells by IL-18. J Immunol (2003) 0.95

Role of interleukin-18 in host defense against disseminated Candida albicans infection. Infect Immun (2002) 0.94

Anti-interleukin-18 therapy in murine models of inflammatory bowel disease. Pathobiology (2003) 0.88

Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J Immunol (2003) 0.86

Generation of neutralizing mouse anti-mouse IL-18 antibodies for inhibition of inflammatory responses in vivo. J Immunol Methods (2002) 0.80

Articles by these authors

HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12

Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity (2004) 6.46

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature (2006) 5.34

Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci U S A (2004) 4.93

SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol (2003) 4.90

NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell (2007) 4.56

Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell (2011) 4.12

Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity (2011) 3.97

A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity (2007) 3.83

A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell (2009) 3.63

Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol (2006) 3.19

5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat Med (2008) 3.13

Disparate individual fates compose robust CD8+ T cell immunity. Science (2013) 2.80

Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2003) 2.66

MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66

CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology (2006) 2.39

Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity (2005) 2.35

Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest (2013) 2.23

CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity (2006) 2.06

Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer. Cancer Immunol Immunother (2007) 2.05

Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis (2006) 2.02

Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med (2006) 1.98

Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest (2004) 1.96

Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe (2008) 1.96

Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nat Methods (2005) 1.93

TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell (2008) 1.91

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc Natl Acad Sci U S A (2002) 1.85

Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol (2003) 1.81

Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol (2010) 1.81

EchoBASE: an integrated post-genomic database for Escherichia coli. Nucleic Acids Res (2005) 1.67

Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volume index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water index. Crit Care Med (2008) 1.61

NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60

Stem cell-like plasticity of naïve and distinct memory CD8+ T cell subsets. Semin Immunol (2009) 1.59

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc Natl Acad Sci U S A (2011) 1.55

Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat Med (2002) 1.54

Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest (2007) 1.51

Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposure. J Immunol (2002) 1.51

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion (2010) 1.49

A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat Immunol (2011) 1.48

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur J Immunol (2006) 1.45

Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med (2007) 1.44

Mouse phenotyping. Methods (2010) 1.43

Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J Exp Med (2003) 1.41

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood (2005) 1.39

CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest (2011) 1.39

Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J Immunol (2004) 1.38

Importance of integrin LFA-1 deactivation for the generation of immune responses. J Exp Med (2005) 1.37

Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol (2004) 1.35

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals. Vaccine (2003) 1.34

Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. Blood (2008) 1.34

Discovery of chromone-based inhibitors of the transcription factor STAT5. Chembiochem (2008) 1.34

Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity. Eur J Immunol (2007) 1.33

CpG-DNA aided cross-priming by cross-presenting B cells. J Immunol (2004) 1.32

Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology (2010) 1.27

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine (2008) 1.26

Generation and characterization of dickkopf3 mutant mice. Mol Cell Biol (2006) 1.26

Systemic first-line phenotyping. Methods Mol Biol (2009) 1.26

Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells. Eur J Immunol (2006) 1.25

Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc Natl Acad Sci U S A (2013) 1.24

Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens. J Immunol Methods (2007) 1.24

Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol (2011) 1.23

Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology (2007) 1.23

Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity (2007) 1.21

Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity (2005) 1.21

Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum (2008) 1.20

Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur J Immunol (2004) 1.19

Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells. J Immunol (2003) 1.18

Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur J Immunol (2004) 1.13

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells. Nat Commun (2011) 1.12

Failure of HY-specific thymocytes to escape negative selection by receptor editing. Immunity (2002) 1.12

Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation (2007) 1.11

Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity. Blood (2009) 1.10

Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells. Cell Stem Cell (2009) 1.10

Innovations in phenotyping of mouse models in the German Mouse Clinic. Mamm Genome (2012) 1.09

Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology (2012) 1.07

Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity. J Immunol (2011) 1.07

CD8+ T cell differentiation in the aging immune system: until the last clone standing. Curr Opin Immunol (2011) 1.07

Sex-dependent susceptibility to Listeria monocytogenes infection is mediated by differential interleukin-10 production. Infect Immun (2005) 1.06

Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun (2007) 1.06

TRIF signaling stimulates translation of TNF-alpha mRNA via prolonged activation of MK2. J Immunol (2010) 1.06

Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg (2007) 1.05

Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology (2003) 1.05

Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells. Proc Natl Acad Sci U S A (2010) 1.05

Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice. J Biol Chem (2011) 1.05

The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Eur J Immunol (2009) 1.04

A novel N-ethyl-N-nitrosourea-induced mutation in phospholipase Cγ2 causes inflammatory arthritis, metabolic defects, and male infertility in vitro in a murine model. Arthritis Rheum (2011) 1.04

Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors. Hum Mol Genet (2013) 1.03

Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J Am Soc Nephrol (2005) 1.03

Protective immunity towards intracellular pathogens. Curr Opin Immunol (2006) 1.03

Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs. Blood (2011) 1.03

Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol (2011) 1.03

Mass spectrometry based metabolomics and enzymatic assays for functional genomics. Curr Opin Microbiol (2009) 1.02

Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor. Blood (2012) 1.02

Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. Blood (2007) 1.02

Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens. Immunol Lett (2007) 1.02